Showing results (1-10 of 648) with videos related to
Sort By:
Pageof 65
American Heart Journal|March 31, 2007
The new heart failure guidelines: strategies for implementationChristopher M O'ConnorClinical Cardiology|September 17, 2014
Modern obesity pharmacotherapy: weighing cardiovascular risk and benefitJonathan W Cunningham, Stephen D WiviottNEJM Evidence|February 6, 2024
Clinical Translation of Cardiovascular Biomarkers - A Long and Uncertain RoadJonathan W Cunningham, Marc A PfefferMed (New York, N.Y.)|July 12, 2025
Aldosterone synthase inhibition in mineralocorticoid blockade: From hypertension to cardiovascular and kidney diseaseJonathan W Cunningham, Carolyn S P LamHeart Failure Clinics|October 2, 2007
Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderlyChristopher M O'Connor, Pradeep ArumughamHeart Failure Clinics|September 20, 2011
Lessons learned from clinical trials in acute heart failure: phase 3 drug trialsChristopher M O'Connor, Mona FiuzatClinics in Geriatric Medicine|November 28, 2006
Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderlyChristopher M O'Connor, Pradeep ArumughamJACC. Basic to Translational Science|August 12, 2022
Cardiac Xenotransplantation: Challenges, Evolution, and AdvancesJacinthe Boulet, Jonathan W Cunningham, Mandeep R MehraExpert Review of Cardiovascular Therapy|July 31, 2010
Cell therapy for heart failure: the need for a new therapeutic strategyThomas J Povsic, Christopher M O'ConnorCurrent Heart Failure Reports|August 24, 2010
Depression after myocardial infarctionMelvin R Echols, Christopher M O'ConnorPageof 65